Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue. ADCs are part of a specialized subset of highly potent APIs. This technically challenging type of therapy combines innovations from biotechnology and chemistry to form a new class of highly potent biopharmaceutical drugs.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Antibody Drug Conjugates (ADCs) market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Antibody Drug Conjugates (ADCs) market. Detailed analysis of key players, along with key growth strategies adopted by Antibody Drug Conjugates (ADCs) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Takeda Pharmaceuticals
Novartis
Kairos Therapeutics
Seattle Genetics
Genmab
Bayer
Astellas Pharma
AbGenomics
Roche
AbbVie
Pfizer
ADC Therapeutics
By Type:
Bayer Technology
ImmunoGen Technology
Immunomedics Technology
By End-User:
Hospital
Clinics
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Antibody Drug Conjugates (ADCs) Market
-
1.3 Market Segment by Type
-
1.3.1 USA Antibody Drug Conjugates (ADCs) Market Size and Growth Rate of Bayer Technology from 2016 to 2027
-
1.3.2 USA Antibody Drug Conjugates (ADCs) Market Size and Growth Rate of ImmunoGen Technology from 2016 to 2027
-
1.3.3 USA Antibody Drug Conjugates (ADCs) Market Size and Growth Rate of Immunomedics Technology from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Antibody Drug Conjugates (ADCs) Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 USA Antibody Drug Conjugates (ADCs) Market Size and Growth Rate of Clinics from 2016 to 2027
-
1.4.3 USA Antibody Drug Conjugates (ADCs) Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Antibody Drug Conjugates (ADCs) Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Antibody Drug Conjugates (ADCs) Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Antibody Drug Conjugates (ADCs) Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Antibody Drug Conjugates (ADCs) Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Antibody Drug Conjugates (ADCs) Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Antibody Drug Conjugates (ADCs) by Major Types
-
3.4.1 Market Size and Growth Rate of Bayer Technology
-
3.4.2 Market Size and Growth Rate of ImmunoGen Technology
-
3.4.3 Market Size and Growth Rate of Immunomedics Technology
4 Segmentation of Antibody Drug Conjugates (ADCs) Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Antibody Drug Conjugates (ADCs) by Major End-Users
-
4.4.1 Market Size and Growth Rate of Antibody Drug Conjugates (ADCs) in Hospital
-
4.4.2 Market Size and Growth Rate of Antibody Drug Conjugates (ADCs) in Clinics
-
4.4.3 Market Size and Growth Rate of Antibody Drug Conjugates (ADCs) in Others
5 Market Analysis by Regions
-
5.1 USA Antibody Drug Conjugates (ADCs) Production Analysis by Regions
-
5.2 USA Antibody Drug Conjugates (ADCs) Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Antibody Drug Conjugates (ADCs) Landscape Analysis
-
6.1 West USA Antibody Drug Conjugates (ADCs) Landscape Analysis by Major Types
-
6.2 West USA Antibody Drug Conjugates (ADCs) Landscape Analysis by Major End-Users
7 South USA Antibody Drug Conjugates (ADCs) Landscape Analysis
-
7.1 South USA Antibody Drug Conjugates (ADCs) Landscape Analysis by Major Types
-
7.2 South USA Antibody Drug Conjugates (ADCs) Landscape Analysis by Major End-Users
8 Middle West USA Antibody Drug Conjugates (ADCs) Landscape Analysis
-
8.1 Middle West USA Antibody Drug Conjugates (ADCs) Landscape Analysis by Major Types
-
8.2 Middle West USA Antibody Drug Conjugates (ADCs) Landscape Analysis by Major End-Users
9 Northeast USA Antibody Drug Conjugates (ADCs) Landscape Analysis
-
9.1 Northeast USA Antibody Drug Conjugates (ADCs) Landscape Analysis by Major Types
-
9.2 Northeast USA Antibody Drug Conjugates (ADCs) Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Takeda Pharmaceuticals
-
10.1.1 Takeda Pharmaceuticals Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Novartis
-
10.2.1 Novartis Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Kairos Therapeutics
-
10.3.1 Kairos Therapeutics Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Seattle Genetics
-
10.4.1 Seattle Genetics Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Genmab
-
10.5.1 Genmab Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Bayer
-
10.6.1 Bayer Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Astellas Pharma
-
10.7.1 Astellas Pharma Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 AbGenomics
-
10.8.1 AbGenomics Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Roche
-
10.9.1 Roche Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 AbbVie
-
10.10.1 AbbVie Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Pfizer
-
10.11.1 Pfizer Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 ADC Therapeutics
-
10.12.1 ADC Therapeutics Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Antibody Drug Conjugates (ADCs) Market Size and Growth Rate of Bayer Technology from 2016 to 2027
-
Figure USA Antibody Drug Conjugates (ADCs) Market Size and Growth Rate of ImmunoGen Technology from 2016 to 2027
-
Figure USA Antibody Drug Conjugates (ADCs) Market Size and Growth Rate of Immunomedics Technology from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Antibody Drug Conjugates (ADCs) Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure USA Antibody Drug Conjugates (ADCs) Market Size and Growth Rate of Clinics from 2016 to 2027
-
Figure USA Antibody Drug Conjugates (ADCs) Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Antibody Drug Conjugates (ADCs) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Antibody Drug Conjugates (ADCs) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Antibody Drug Conjugates (ADCs) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Antibody Drug Conjugates (ADCs) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Antibody Drug Conjugates (ADCs) Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Antibody Drug Conjugates (ADCs)
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Antibody Drug Conjugates (ADCs) by Different Types from 2016 to 2027
-
Table Consumption Share of Antibody Drug Conjugates (ADCs) by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Bayer Technology
-
Figure Market Size and Growth Rate of ImmunoGen Technology
-
Figure Market Size and Growth Rate of Immunomedics Technology
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Antibody Drug Conjugates (ADCs) by Different End-Users from 2016 to 2027
-
Table Consumption Share of Antibody Drug Conjugates (ADCs) by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Clinics
-
Figure Market Size and Growth Rate of Others
-
Table USA Antibody Drug Conjugates (ADCs) Production by Regions
-
Table USA Antibody Drug Conjugates (ADCs) Production Share by Regions
-
Figure USA Antibody Drug Conjugates (ADCs) Production Share by Regions in 2016
-
Figure USA Antibody Drug Conjugates (ADCs) Production Share by Regions in 2021
-
Figure USA Antibody Drug Conjugates (ADCs) Production Share by Regions in 2027
-
Table USA Antibody Drug Conjugates (ADCs) Consumption by Regions
-
Table USA Antibody Drug Conjugates (ADCs) Consumption Share by Regions
-
Figure USA Antibody Drug Conjugates (ADCs) Consumption Share by Regions in 2016
-
Figure USA Antibody Drug Conjugates (ADCs) Consumption Share by Regions in 2021
-
Figure USA Antibody Drug Conjugates (ADCs) Consumption Share by Regions in 2027
-
Table West USA Antibody Drug Conjugates (ADCs) Consumption by Types from 2016 to 2027
-
Table West USA Antibody Drug Conjugates (ADCs) Consumption Share by Types from 2016 to 2027
-
Figure West USA Antibody Drug Conjugates (ADCs) Consumption Share by Types in 2016
-
Figure West USA Antibody Drug Conjugates (ADCs) Consumption Share by Types in 2021
-
Figure West USA Antibody Drug Conjugates (ADCs) Consumption Share by Types in 2027
-
Table West USA Antibody Drug Conjugates (ADCs) Consumption by End-Users from 2016 to 2027
-
Table West USA Antibody Drug Conjugates (ADCs) Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Antibody Drug Conjugates (ADCs) Consumption Share by End-Users in 2016
-
Figure West USA Antibody Drug Conjugates (ADCs) Consumption Share by End-Users in 2021
-
Figure West USA Antibody Drug Conjugates (ADCs) Consumption Share by End-Users in 2027
-
Table South USA Antibody Drug Conjugates (ADCs) Consumption by Types from 2016 to 2027
-
Table South USA Antibody Drug Conjugates (ADCs) Consumption Share by Types from 2016 to 2027
-
Figure South USA Antibody Drug Conjugates (ADCs) Consumption Share by Types in 2016
-
Figure South USA Antibody Drug Conjugates (ADCs) Consumption Share by Types in 2021
-
Figure South USA Antibody Drug Conjugates (ADCs) Consumption Share by Types in 2027
-
Table South USA Antibody Drug Conjugates (ADCs) Consumption by End-Users from 2016 to 2027
-
Table South USA Antibody Drug Conjugates (ADCs) Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Antibody Drug Conjugates (ADCs) Consumption Share by End-Users in 2016
-
Figure South USA Antibody Drug Conjugates (ADCs) Consumption Share by End-Users in 2021
-
Figure South USA Antibody Drug Conjugates (ADCs) Consumption Share by End-Users in 2027
-
Table Middle West USA Antibody Drug Conjugates (ADCs) Consumption by Types from 2016 to 2027
-
Table Middle West USA Antibody Drug Conjugates (ADCs) Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Antibody Drug Conjugates (ADCs) Consumption Share by Types in 2016
-
Figure Middle West USA Antibody Drug Conjugates (ADCs) Consumption Share by Types in 2021
-
Figure Middle West USA Antibody Drug Conjugates (ADCs) Consumption Share by Types in 2027
-
Table Middle West USA Antibody Drug Conjugates (ADCs) Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Antibody Drug Conjugates (ADCs) Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Antibody Drug Conjugates (ADCs) Consumption Share by End-Users in 2016
-
Figure Middle West USA Antibody Drug Conjugates (ADCs) Consumption Share by End-Users in 2021
-
Figure Middle West USA Antibody Drug Conjugates (ADCs) Consumption Share by End-Users in 2027
-
Table Northeast USA Antibody Drug Conjugates (ADCs) Consumption by Types from 2016 to 2027
-
Table Northeast USA Antibody Drug Conjugates (ADCs) Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Antibody Drug Conjugates (ADCs) Consumption Share by Types in 2016
-
Figure Northeast USA Antibody Drug Conjugates (ADCs) Consumption Share by Types in 2021
-
Figure Northeast USA Antibody Drug Conjugates (ADCs) Consumption Share by Types in 2027
-
Table Northeast USA Antibody Drug Conjugates (ADCs) Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Antibody Drug Conjugates (ADCs) Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Antibody Drug Conjugates (ADCs) Consumption Share by End-Users in 2016
-
Figure Northeast USA Antibody Drug Conjugates (ADCs) Consumption Share by End-Users in 2021
-
Figure Northeast USA Antibody Drug Conjugates (ADCs) Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Takeda Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Takeda Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Takeda Pharmaceuticals
-
Table Product and Service Introduction of Takeda Pharmaceuticals
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Kairos Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kairos Therapeutics
-
Figure Sales and Growth Rate Analysis of Kairos Therapeutics
-
Figure Revenue and Market Share Analysis of Kairos Therapeutics
-
Table Product and Service Introduction of Kairos Therapeutics
-
Table Company Profile and Development Status of Seattle Genetics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Seattle Genetics
-
Figure Sales and Growth Rate Analysis of Seattle Genetics
-
Figure Revenue and Market Share Analysis of Seattle Genetics
-
Table Product and Service Introduction of Seattle Genetics
-
Table Company Profile and Development Status of Genmab
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genmab
-
Figure Sales and Growth Rate Analysis of Genmab
-
Figure Revenue and Market Share Analysis of Genmab
-
Table Product and Service Introduction of Genmab
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of Astellas Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma
-
Figure Sales and Growth Rate Analysis of Astellas Pharma
-
Figure Revenue and Market Share Analysis of Astellas Pharma
-
Table Product and Service Introduction of Astellas Pharma
-
Table Company Profile and Development Status of AbGenomics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbGenomics
-
Figure Sales and Growth Rate Analysis of AbGenomics
-
Figure Revenue and Market Share Analysis of AbGenomics
-
Table Product and Service Introduction of AbGenomics
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of ADC Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ADC Therapeutics
-
Figure Sales and Growth Rate Analysis of ADC Therapeutics
-
Figure Revenue and Market Share Analysis of ADC Therapeutics
-
Table Product and Service Introduction of ADC Therapeutics
-
